Items Tagged ‘Recurrent Liver Cancer’

May 27th, 2014

Liver Cancer Drug Livatag® Granted U.S. Food and Drug Administration Fast Track Designation


The drug Livatag® (doxorubicin Transdrug™) has received fast-track designation from the U.S. Food and Drug Administration (FDA) for the treatment of primary liver cancer after treatment with Nexavar® (sorafenib). This was recently announced in a press release from BioAlliance Pharma SA, manufacturers of Livatag.[1] The liver is the largest organ in the body and is […]

View full entry

Tags: Liver Cancer, News, Recurrent Liver Cancer, Stage IV Liver Cancer

May 31st, 2011

Cabozantinib Shows Promise against Bone Metastases


The investigational drug cabozantinib is showing promise against several types of advanced cancer, and may also reduce or eliminate bone metastases (cancer that has spread to the bone) in some patients. These results will be presented at the 2011 annual meeting of the American Society of Clinical Oncology. Metastatic cancer refers to cancer that has […]

View full entry

Tags: Breast Cancer, Liver Cancer, Melanoma, Metastatic Breast Cancer, News, Ovarian Cancer, Prostate Cancer, Recurrent Breast Cancer, Recurrent Liver Cancer, Recurrent Melanoma, Recurrent Ovarian Cancer, Refactory/Recurrent Prostate Cancer